Diabetes Mellitus-induced Bone Fragility

Internal Medicine
Ippei Kanazawa, Toshitsugu Sugimoto

Abstract

Accumulating evidence has shown that the risk of osteoporotic fractures is increased in patients with diabetes mellitus (DM). Thus, DM-induced bone fragility has been recently recognized as a diabetic complication. Because the fracture risk is independent of the reduction in bone mineral density, deterioration of the bone quality may be the main cause of bone fragility. Although its mechanism remains poorly understood, accumulated collagen cross-links of advanced glycation end-products (AGEs) and dysfunctions of osteoblast and osteocyte may be involved. Previous studies have suggested that various diabetes-related factors, such as chronic hyperglycemia, insulin, insulin-like growth factor-I, AGEs, and homocysteine, are associated with the risk of bone fragility caused by impaired bone formation and bone remodeling. Furthermore, several anti-diabetic drugs are known to affect bone metabolism and fracture risk. We herein review the association between DM and fracture risk as well as the mechanism of DM-induced bone fragility based on recent evidence.

References

Dec 1, 1989·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·K K PunP W Ho
Nov 1, 1994·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A Kanis
Dec 24, 1996·Proceedings of the National Academy of Sciences of the United States of America·T H RosenquistJ Selhub
Jul 6, 2000·Journal of Endocrinological Investigation·S A KeminkA G Smals
May 14, 2004·The New England Journal of Medicine·Joyce B J van MeursAndré G Uitterlinden
Nov 19, 2004·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Mehrsheed SinakiKenton R Kaufman
Sep 27, 2005·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Mathew S MaurerHuai Cheng
Mar 28, 2006·European Journal of Pharmacology·Ana M CortizoLeón Schurman
Jun 1, 2006·The Journal of Clinical Endocrinology and Metabolism·Harald DobnigAstrid Fahrleitner-Pammer
Jun 14, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M SaitoK Marumo
Jun 28, 2006·Diabetes Care·Mohsen JanghorbaniFrank Hu
Oct 28, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P Vestergaard
Jun 19, 2007·American Journal of Epidemiology·Mohsen JanghorbaniFrank B Hu
Jul 17, 2007·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·I KanazawaT Sugimoto
Jul 31, 2007·Molecular and Cellular Biochemistry·Natalia MercerAna Maria Cortizo
Nov 3, 2007·Journal of Cellular Biochemistry·Laura R McCabe
Dec 7, 2007·Diabetes Care·Ann V SchwartzUNKNOWN Health, Aging, and Body Composition Study
Dec 7, 2007·Nature Medicine·Yihong WanRonald M Evans
Dec 28, 2007·The Journal of Clinical Endocrinology and Metabolism·Masahiro YamamotoToshitsugu Sugimoto
Feb 15, 2008·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·L SchurmanA M Cortizo
Mar 20, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·L Joseph MeltonSundeep Khosla
Dec 4, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Masahiro YamamotoToshitsugu Sugimoto
Dec 17, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Yoon K LokeCurt D Furberg
Apr 23, 2009·The Journal of Clinical Endocrinology and Metabolism·Ann V SchwartzUNKNOWN Health, Aging, and Body Composition Study
May 28, 2009·The Journal of Clinical Endocrinology and Metabolism·Ippei KanazawaToshitsugu Sugimoto
Jun 2, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M SaitoA Shinohara

❮ Previous
Next ❯

Citations

Dec 19, 2019·Periodontology 2000·Dana T GravesYingming Yang
Mar 29, 2020·Critical Reviews in Clinical Laboratory Sciences·Wojciech J BilinskiGrazyna Sypniewska
Feb 1, 2020·Current Osteoporosis Reports·Zhen HuangDana T Graves
Nov 4, 2020·The Journal of Clinical Endocrinology and Metabolism·Sarah CharlierChristoph R Meier
Feb 2, 2021·Current Osteoporosis Reports·Julie Kristine KnudsenSuzette Sørensen
Mar 26, 2021·Clinical Oral Investigations·Alessandra Julie SchusterFernanda Faot
Apr 15, 2021·Curēus·Cheena KumariPousette Hamid

❮ Previous
Next ❯

Methods Mentioned

BETA
glycation
biopsy
X-ray
ELISA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical calcium
Ippei Kanazawa, Toshitsugu Sugimoto
Nihon rinsho. Japanese journal of clinical medicine
Ippei Kanazawa
© 2022 Meta ULC. All rights reserved